Commercial Law, 2019 Bar — Question A.9-a

ESSAY

X Pharmaceuticals, Inc. has been manufacturing the antibiotic ointment Marvelopis, which is covered by a patent expiring in the year 2020. In January 2019, the company filed an application for a new patent for Disilopis, which although constituting the same substance as Marvelopis, is no longer treated as an antibiotic but is targeted and marketed for a new use, i.e., skin whitening. (a) What are the three (3) requisites of patentability under the Intellectual Property Code?

You can write freely without an account. Sign in to reveal the suggested answer and track your progress.